These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 10213494

  • 21. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
    Michaelson JS, Leder P.
    Oncogene; 2001 Aug 23; 20(37):5093-9. PubMed ID: 11526497
    [Abstract] [Full Text] [Related]

  • 22. Control of the three-dimensional growth pattern of mammary epithelium: role of genes of the Wnt and erbB families studied using reconstituted epithelium.
    Edwards PA.
    Biochem Soc Symp; 1998 Aug 23; 63():21-34. PubMed ID: 9513708
    [Abstract] [Full Text] [Related]

  • 23. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes.
    Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP.
    Recent Prog Horm Res; 1996 Aug 23; 51():159-86; discussion 186-8. PubMed ID: 8701078
    [Abstract] [Full Text] [Related]

  • 24. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE.
    Cancer Res; 2000 Dec 15; 60(24):6901-10. PubMed ID: 11156389
    [Abstract] [Full Text] [Related]

  • 25. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH.
    Virology; 1995 Oct 01; 212(2):490-9. PubMed ID: 7571419
    [Abstract] [Full Text] [Related]

  • 26. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
    Chooi KF, Carter DA, Biswas S, Lightman SL, Ho MY, Murphy D.
    Cancer Res; 1994 Dec 15; 54(24):6434-40. PubMed ID: 7987839
    [Abstract] [Full Text] [Related]

  • 27. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
    Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G.
    Am J Pathol; 1995 Oct 15; 147(4):1081-96. PubMed ID: 7573353
    [Abstract] [Full Text] [Related]

  • 28. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW, Wagner KU, Hennighausen L.
    Oncogene; 2001 Oct 25; 20(48):7115-9. PubMed ID: 11704837
    [Abstract] [Full Text] [Related]

  • 29. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.
    Rowse GJ, Ritland SR, Gendler SJ.
    Cancer Res; 1998 Jun 15; 58(12):2675-9. PubMed ID: 9635596
    [Abstract] [Full Text] [Related]

  • 30. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI, Leder P.
    Oncogene; 1996 Dec 19; 13(12):2507-15. PubMed ID: 9000125
    [Abstract] [Full Text] [Related]

  • 31. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct 19; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
    Zhang X, Mehta RG, Lantvit DD, Coschigano KT, Kopchick JJ, Green JE, Hedayat S, Christov KT, Ray VH, Unterman TG, Swanson SM.
    Carcinogenesis; 2007 Jan 19; 28(1):143-50. PubMed ID: 16916863
    [Abstract] [Full Text] [Related]

  • 33. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 34. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
    Weinstein EJ, Leder P.
    Cancer Res; 2000 Jul 15; 60(14):3856-61. PubMed ID: 10919660
    [Abstract] [Full Text] [Related]

  • 35. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
    Silberstein GB, Van Horn K, Hrabeta-Robinson E, Compton J.
    J Endocrinol; 2006 Aug 15; 190(2):225-39. PubMed ID: 16899557
    [Abstract] [Full Text] [Related]

  • 36. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
    Yin YJ, Katz V, Salah Z, Maoz M, Cohen I, Uziely B, Turm H, Grisaru-Granovsky S, Suzuki H, Bar-Shavit R.
    Cancer Res; 2006 May 15; 66(10):5224-33. PubMed ID: 16707447
    [Abstract] [Full Text] [Related]

  • 37. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
    Manhès C, Kayser C, Bertheau P, Kelder B, Kopchick JJ, Kelly PA, Touraine P, Goffin V.
    J Endocrinol; 2006 Aug 15; 190(2):271-85. PubMed ID: 16899561
    [Abstract] [Full Text] [Related]

  • 38. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.
    Oncogene; 2000 Dec 07; 19(52):6007-14. PubMed ID: 11146552
    [Abstract] [Full Text] [Related]

  • 39. Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function.
    Humphreys RC, Rosen JM.
    Cell Growth Differ; 1997 Aug 07; 8(8):839-49. PubMed ID: 9269893
    [Abstract] [Full Text] [Related]

  • 40. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
    Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.